| Fiscal period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Period End Date | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 |
|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1,709.10 |
| Product revenue | 834.80 | 936.10 | 1,135.50 | 1,051.40 | 1,005.20 | 1,004.20 | 783.10 | 726.40 | 808.80 | -- |
| Service revenue | 165.60 | 170.00 | 156.90 | 147.50 | 131.10 | 126.10 | 97.30 | 85.00 | 97.50 | -- |
| Total Revenues | 1,000.40 | 1,106.10 | 1,292.40 | 1,198.90 | 1,136.30 | 1,130.30 | 880.40 | 811.40 | 906.30 | 1,709.10 |
| Cost of sales | -- | -- | -- | -- | -- | -- | -- | -- | -- | 891.00 |
| Service cost of revenues | 75.50 | 77.80 | 67.60 | 59.60 | 49.80 | 49.70 | 46.80 | 50.20 | 61.20 | -- |
| Product cost of revenues | 335.20 | 364.90 | 421.30 | 391.70 | 388.50 | 394.80 | 314.70 | 260.90 | 278.10 | -- |
| Amortization of acquired technologies | 13.80 | 24.60 | 30.00 | 33.20 | 32.70 | 34.40 | 26.70 | 14.30 | 17.30 | 39.40 |
| Gross Profit | 575.90 | 638.80 | 773.50 | 714.40 | 665.30 | 651.40 | 492.20 | 486.00 | 549.70 | 778.70 |
| Amortization of goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Impairment of goodwill | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | 91.40 | -- |
| Amortization of other intangibles | 6.30 | 8.70 | 9.70 | 33.30 | 35.10 | 38.10 | 21.00 | 14.00 | 14.60 | 19.80 |
| Research and development | 201.90 | 206.90 | 213.20 | 203.00 | 193.60 | 187.00 | 133.30 | 136.30 | 166.40 | 313.20 |
| Acquired in-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 333.30 | 328.70 | 365.70 | 337.50 | 315.00 | 343.50 | 324.50 | 300.50 | 351.10 | 463.50 |
| Restructuring charges | 13.60 | 12.10 | (0.10) | (1.60) | 3.50 | 15.40 | 8.30 | 21.60 | 10.50 | 34.50 |
| Reduction of intangibles and loss / gain on long-lived assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 555.10 | 556.40 | 588.50 | 572.20 | 547.20 | 584.00 | 487.10 | 472.40 | 634.00 | 831.00 |
| Operating Income (Loss) | 20.80 | 82.40 | 185.00 | 142.20 | 118.10 | 67.40 | 5.10 | 13.60 | (84.30) | (52.30) |
| Interest Expenses | 30.90 | 27.10 | 23.30 | 36.10 | 33.70 | 34.30 | 47.30 | 43.20 | 35.70 | 34.00 |
| Impairment of investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on sale of subsidiary | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on sale of investments | -- | -- | -- | -- | -- | (0.50) | (0.10) | 203.10 | 71.60 | -- |
| Gain (loss) on equity method investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Activity related to equity investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and other, net | 21.70 | 7.60 | 5.20 | 3.30 | 9.60 | 6.70 | 9.70 | 13.10 | 2.50 | 3.40 |
| Loss on sale of available-for-sale investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Reduction in fair value of available-for-sale investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss on convertible note settlement | -- | -- | (101.80) | -- | -- | -- | -- | -- | -- | -- |
| Loss on convertible note modification | -- | (2.20) | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (Loss) before income taxes and cumulative effect of an accounting change | 11.60 | 60.70 | 65.10 | 109.40 | 94.00 | 39.30 | (32.60) | 186.60 | (45.90) | (82.90) |
| Federal: Current | 0.30 | 27.60 | -- | -- | -- | -- | (4.50) | -- | -- | -- |
| Federal: Deferred | -- | 5.00 | -- | -- | -- | -- | (1.70) | 1.00 | (26.20) | 2.30 |
| State: Current | 3.30 | 2.60 | (2.20) | 20.10 | 2.70 | 0.10 | -- | 0.20 | -- | -- |
| State: Deferred | -- | -- | -- | -- | -- | -- | (0.10) | -- | (1.50) | 0.10 |
| Foreign: Current | 32.80 | -- | 63.20 | 44.80 | 50.10 | 33.30 | 22.00 | 18.00 | 21.30 | (2.70) |
| Foreign: Deferred | 1.00 | -- | (11.40) | (1.60) | 12.50 | (1.90) | (2.30) | 2.10 | 10.90 | 5.50 |
| Provision of (benefit for) income taxes | 37.40 | 35.20 | 49.60 | 63.30 | 65.30 | 31.50 | 13.40 | 21.30 | 4.50 | 5.20 |
| Income (loss) from continuing operations, net of tax | -- | -- | -- | 46.10 | 28.70 | 7.80 | (46.00) | 165.30 | (50.40) | (88.10) |
| Income (loss) from Discontinued Operations, net of tax | -- | -- | -- | -- | -- | (2.40) | -- | 1.60 | (48.80) | -- |
| Income (Loss) before cumulative effect of an accounting change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of an accounting change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) Available to Common Shareholders | (25.80) | 25.50 | 15.50 | 46.10 | 28.70 | 5.40 | (46.00) | 166.90 | (99.20) | (88.10) |
| EPS (Basic) : Continuing operations | -- | -- | -- | 0.20 | 0.13 | 0.03 | (0.20) | 0.72 | (0.22) | (0.38) |
| EPS (Basic) : Discontinued operations | -- | -- | -- | -- | -- | (0.01) | -- | 0.01 | (0.20) | -- |
| Net Earnings Per Share (Basic) | (0.12) | 0.11 | 0.07 | 0.20 | 0.13 | 0.02 | (0.20) | 0.73 | (0.42) | (0.38) |
| EPS (Diluted) : Continuing operations | -- | -- | -- | 0.20 | 0.12 | 0.03 | (0.20) | 0.70 | (0.22) | (0.38) |
| EPS (Diluted) : Discontinued operations | -- | -- | -- | -- | -- | (0.01) | -- | 0.01 | (0.20) | -- |
| Net Earnings Per Share (Diluted) | (0.12) | 0.11 | 0.07 | 0.20 | 0.12 | 0.02 | (0.20) | 0.71 | (0.42) | (0.38) |
| Weighted Average Shares Outstanding (Basic) | 222.60 | 224.60 | 230.90 | 228.70 | 229.40 | 228.10 | 227.10 | 229.90 | 234.00 | 232.70 |
| Weighted Average Shares Outstanding (Diluted) | 222.60 | 226.60 | 238.20 | 235.90 | 233.70 | 231.20 | 227.10 | 234.50 | 234.00 | 232.70 |